Item 2.01. Completion of Acquisition or Disposition of Assets.
On September 17, 2018, Pharma-Bio Serv, Inc. (the Company) completed the previously announced sale of substantially all of the assets of its laboratory business (the Laboratory Assets) pursuant to the Asset Purchase Agreement, dated August 13, 2018, by and between Scienza Labs, Inc., a subsidiary of the Company, and Romark Global Pharma, LLC for $5 million ($1.75 million in cash, $3.0 million in the form of a promissory note payable over two years, and $0.25 million from the application of a previously paid deposit).
On September 21, 2018, the Company issued a press release announcing the sale of the Laboratory Assets. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
